Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2016; 8(02): 123-125
DOI: 10.4103/0974-2727.180796
Case Report

Xp11.2 Translocation Renal Cell Carcinoma Diagnosed by Immunohistochemistry and Cytogenetics

Biswajit Dey
Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
,
Bhawana Badhe
Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
,
Krishna Kumar Govindarajan
Department of Paediatric Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
,
Ranjith Arumbakkam Ramesh
Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
› Author Affiliations Financial support and sponsorship: Nil.
› Further Information
Also available at
  PDF Download Permissions and Reprints

ABSTRACT

Xp11.2 translocation renal cell carcinomas (TRCCs) are a group of neoplasms with distinct clinical, histopathological appearance, immunohistochemical, and cytogenetic profile. We report a case of Xp11.2 translocation TRCC in an 11-year-old male diagnosed based on immunohistochemistry and fluorescence in situ hybridization.

Key words:

Immunohistochemistry - renal cell carcinoma - translocation


Publication History

Article published online:
19 April 2020

© 2016.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Argani P, Ladanyi M. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (World Health Organization Classification of Tumours). Lyon, France: IARC; 2004. p. 37-8.
  • 2 Armah HB, Parwani AV. Xp11.2 translocation renal cell carcinoma. Arch Pathol Lab Med 2010;134:124-9.
  • 3 Kmetec A, Jeruc J. Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype. Radiol Oncol 2014;48:197-202.
  • 4 Ahluwalia P, Nair B, Kumar G. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: A rare case report with review of the literature. Case Rep Urol 2013;2013:810590.
  • 5 Parihar A, Tickoo SK, Kumar S, Arora VK. Xp11 translocation renal cell carcinoma morphologically mimicking clear cell-papillary renal cell carcinoma in an adult patient: Report of a case expanding the morphologic spectrum of Xp11 translocation renal cell carcinomas. Int J Surg Pathol 2015;23:234-7.
  • 6 Kothari KS, Sathe PA, Naik LP, Kandalkar BM. Xp11 translocation renal cell carcinoma. Indian J Pathol Microbiol 2013;56:471-2.
  • 7 Ross H, Argani P. Xp11 translocation renal cell carcinoma. Pathology 2010;42:369-73.
  • 8 Alexiev BA. Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 (TFE3) fusion. J Cytol Histol 2013;4:173.
  • 9 Kuroda N, Mikami S, Pan CC, Cohen RJ, Hes O, Michal M, et al. Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. Histol Histopathol 2012;27:133-40.